These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 18636169
1. Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors. Reinhard W, Stark K, Neureuther K, Sedlacek K, Fischer M, Baessler A, Weber S, Kaess B, Wiedmann S, Erdmann J, Lieb W, Jeron A, Riegger G, Hengstenberg C. Int J Mol Med; 2008 Aug; 22(2):165-74. PubMed ID: 18636169 [Abstract] [Full Text] [Related]
2. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease. Baessler A, Fischer M, Mayer B, Koehler M, Wiedmann S, Stark K, Doering A, Erdmann J, Riegger G, Schunkert H, Kwitek AE, Hengstenberg C. Hum Mol Genet; 2007 Apr 15; 16(8):887-99. PubMed ID: 17324965 [Abstract] [Full Text] [Related]
3. Lack of association between a common polymorphism near the INSIG2 gene and BMI, myocardial infarction, and cardiovascular risk factors. Wiedmann S, Neureuther K, Stark K, Reinhard W, Kallmünzer B, Baessler A, Fischer M, Linsel-Nitschke P, Erdmann J, Schunkert H, Hengstenberg C. Obesity (Silver Spring); 2009 Jul 15; 17(7):1390-5. PubMed ID: 19197259 [Abstract] [Full Text] [Related]
4. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors. Stark K, Neureuther K, Sedlacek K, Hengstenberg W, Fischer M, Baessler A, Wiedmann S, Jeron A, Holmer S, Erdmann J, Schunkert H, Hengstenberg C. Clin Sci (Lond); 2007 Aug 15; 113(4):213-8. PubMed ID: 17472578 [Abstract] [Full Text] [Related]
5. Association between PPARalpha gene polymorphisms and myocardial infarction. Reinhard W, Stark K, Sedlacek K, Fischer M, Baessler A, Neureuther K, Weber S, Kaess B, Wiedmann S, Mitsching S, Lieb W, Erdmann J, Meisinger C, Doering A, Tolle R, Jeron A, Riegger G, Hengstenberg C. Clin Sci (Lond); 2008 Nov 15; 115(10):301-8. PubMed ID: 18336366 [Abstract] [Full Text] [Related]
6. Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population. Yang W, Huang W, Su S, Li B, Zhao W, Chen S, Gu D. Clin Sci (Lond); 2006 Nov 15; 111(5):333-40. PubMed ID: 16822235 [Abstract] [Full Text] [Related]
7. Association of gene polymorphisms with myocardial infarction in individuals with or without conventional coronary risk factors. Nishihama K, Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Yajima K, Hibino T, Yokoi K, Ichihara S, Metoki N, Yoshida H, Satoh K, Nozawa Y. Int J Mol Med; 2007 Jan 15; 19(1):129-41. PubMed ID: 17143557 [Abstract] [Full Text] [Related]
8. Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study. Horne BD, Carlquist JF, Muhlestein JB, Nicholas ZP, Anderson JL, Intermountain Heart Collaborative Study Group. Am Heart J; 2007 Nov 15; 154(5):969-75. PubMed ID: 17967605 [Abstract] [Full Text] [Related]
9. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers]. Hengstenberg C, Bröckel U, Holmer S, Mayer B, Fischer M, Baessler A, Erdmann J, Lieb W, Löwel H, Riegger G, Schunkert H. Herz; 2002 Nov 15; 27(7):649-61. PubMed ID: 12439636 [Abstract] [Full Text] [Related]
10. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, Kornak U, Essig J, Erxlebe E, Bab I, Kubisch C, de Vernejoul MC, Zimmer A. Hum Mol Genet; 2005 Nov 15; 14(22):3389-96. PubMed ID: 16204352 [Abstract] [Full Text] [Related]
11. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Ortlepp JR, Krantz C, Kimmel M, von Korff A, Vesper K, Schmitz F, Mevissen V, Janssens U, Franke A, Hanrath P, Zerres K, Hoffmann R. Int J Cardiol; 2005 Oct 20; 105(1):90-5. PubMed ID: 16207551 [Abstract] [Full Text] [Related]
12. DNA polymorphisms in the tyrosine hydroxylase and GNB3 genes: association with unexpected death from acute myocardial infarction and increased heart weight. Klintschar M, Stiller D, Schwaiger P, Kleiber M. Forensic Sci Int; 2005 Oct 29; 153(2-3):142-6. PubMed ID: 16139102 [Abstract] [Full Text] [Related]
13. Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels. Gigante B, Vikström M, Meuzelaar LS, Chernogubova E, Silveira A, Hooft FV, Hamsten A, de Faire U. Thromb Haemost; 2009 May 29; 101(5):943-53. PubMed ID: 19404549 [Abstract] [Full Text] [Related]
14. Assessment of genetic risk for myocardial infarction. Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Hibino T, Yokoi K, Ichihara S, Metoki N, Yoshida H, Satoh K, Nozawa Y. Thromb Haemost; 2006 Aug 29; 96(2):220-7. PubMed ID: 16894468 [Abstract] [Full Text] [Related]
15. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I. Coron Artery Dis; 2009 Sep 29; 20(6):383-6. PubMed ID: 19620856 [Abstract] [Full Text] [Related]
18. Extended evidence for association between the melanoma inhibitory activity 3 gene and myocardial infarction. Koch W, Schatke A, Wolferstetter H, Mueller JC, Schömig A, Kastrati A. Thromb Haemost; 2011 Apr 29; 105(4):670-5. PubMed ID: 21264445 [Abstract] [Full Text] [Related]